MetaCap

Mustang Bio Inc. (MBIO)

NASDAQ: MBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4502-0.0098 (-2.13%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Pre-market: 0.4501 -0.02%

MBIO stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.44
52-week range
0.45 – 1.85
Day range
0.45 – 0.4598
Volume / Avg
17.26K / 29.43K
Beta
—
Next earnings
Nov 6, 2026

52-week range

$0.45$1.85

MBIO stock today

On Oct 7, MBIO ended the session at $0.4502, shedding $0.0098 (2.13%), versus the S&P 500's 0.22% decline. Shares are 75.7% below their 52-week high of $1.85 and 0.0% above the 52-week low of $0.45, near the bottom of the past year's range. Mustang Bio has posted a net loss over the last twelve months (EPS of -$0.44), so its P/E ratio is not meaningful.

Mustang Bio's next earnings report is expected on Nov 6, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Mustang Bio

Company profile
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
Waltham, MA

Earnings

Earnings history
Next report
Nov 6, 2026

Mustang Bio peers

Health Care sector
MBIO peer companies
CompanyPrice% ChgMarket capCompare
CVKDCadrenal Therapeutics Inc.0.9723-1.79%$3.47Mvs MBIO
CMNDClearmind Medicine Inc.6.60+13.01%$3.35Mvs MBIO
HCWBHCW Biologics Inc.1.56-0.64%$3.49Mvs MBIO
APVOAptevo Therapeutics Inc.1.84+2.51%$3.33Mvs MBIO
REVBRevelation Biosciences Inc.0.8281+10.12%$3.30Mvs MBIO
XRTXXORTX Therapeutics Inc.1.75+0.87%$3.17Mvs MBIO
EOCNEocene Ltd.3.46+2.91%$3.69Mvs MBIO
SXTCChina SXT Pharmaceuticals Inc. Class A2.83+126.40%$3.74Mvs MBIO

Indexes, lists and sector

Mustang Bio stock FAQ

What is Mustang Bio's stock price today?

MBIO last traded at $0.4502 as of Oct 7, 4:00 PM EDT, down 2.13% on the day. Prices are delayed at least 15 minutes.

When is Mustang Bio's next earnings date?

Mustang Bio is expected to report earnings on Friday, November 6, 2026.

What is the MBIO 52-week high?

The 52-week high for MBIO is $1.85 and the 52-week low is $0.45. The stock is currently 75.7% below its high.

Compare MBIO